Recent studies implicate dysregulated cGAS-STING signaling in neurodegenerative diseases and brain aging, with a prominent contribution to glial activation-associated neuroinflammation, a hallmark of many neurological disorders. This evidence concerns the gene STING1 and neurodegenerative disease.